{"id":20740,"date":"2024-01-19T18:49:03","date_gmt":"2024-01-19T13:19:03","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=20740"},"modified":"2024-01-19T18:49:05","modified_gmt":"2024-01-19T13:19:05","slug":"bridgebio-pharma-secures-billion-dollar-investment","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/","title":{"rendered":"BridgeBio Pharma Secures $1.25 Billion to Propel Genetic Medicine Development"},"content":{"rendered":"
\n
\"Bridgebio<\/figure>\n<\/div>\n\n\n

Introduction<\/strong><\/h2>\n\n\n\n

In a strategic move to accelerate the development and launch of genetic medicines, BridgeBio Pharma has successfully secured up to USD 1.25 billion from Blue Owl Capital and Canada Pension Plan Investment Board. The cornerstone of BridgeBio’s funding initiative involves a strategic agreement with Blue Owl Capital and Canada Pension Plan Investment Board. In a deal worth USD 500 million in cash, BridgeBio Pharma has committed to providing the investors with a 5% royalty on worldwide net sales of its drug, acoramidis, pending FDA approval. This arrangement also includes provisions for a potential acquisition of BridgeBio Pharma, demonstrating the complexity and foresight in the financing strategy.<\/p>\n\n\n\n

Acoramidis: A Potential Game-Changer for BridgeBio Pharma in ATTR Treatment<\/strong><\/h3>\n\n\n\n

Acoramidis, currently under FDA review, represents BridgeBio<\/a> Pharma’s flagship drug in the ATTR space. ATTR is an inherited disease causing abnormal transthyretin protein and the accumulation of amyloid protein in various tissues, including the heart. BridgeBio Pharma aims to go head-to-head with Pfizer’s Vyndaqel, a successful transthyretin stabilizer that generated USD 2.3 billion in sales in the nine months leading up to September 30, 2023.<\/p>\n\n\n\n

Positive Trial Results and Market Strategy<\/strong><\/h3>\n\n\n\n

BridgeBio Pharma’s acoramidis has shown promising results in Phase III trials, with the company emphasizing its superiority as a transthyretin stabilizer based on laboratory tests. The proceeds of the funding are anticipated to not only support the commercial launch of acoramidis but also extend the maturity of BridgeBio Pharma’s loan and provide additional capital for strategic corporate development activities.<\/p>\n\n\n\n

Future Considerations<\/strong> for BridgeBio Pharma<\/strong><\/h3>\n\n\n\n

This financing move is crucial for the company, given its past experiences where drugs approved by the FDA did not significantly contribute to revenue. With a cash position of USD 505.2 million as of September 2023, BridgeBio is strategically using its resources to advance its pipeline, especially in the face of potential competition from Alnylam Pharmaceutical’s Amvuttra, which has approval for treating neuropathy caused by ATTR.<\/p>\n","protected":false},"excerpt":{"rendered":"

Introduction In a strategic move to accelerate the development and launch of genetic medicines, BridgeBio Pharma has successfully secured up to USD 1.25 billion from Blue Owl Capital and Canada Pension Plan Investment Board. The cornerstone of BridgeBio’s funding initiative involves a strategic agreement with Blue Owl Capital and Canada Pension Plan Investment Board. In […]<\/p>\n","protected":false},"author":70,"featured_media":20744,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[287],"tags":[1474,1475,1476],"class_list":["post-20740","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biopharmaceutical","tag-bridgebio","tag-genetic-medicines","tag-laboratory-tests"],"yoast_head":"\nBridgeBio Pharma to Propel Genetic Medicine Development | Blog<\/title>\n<meta name=\"description\" content=\"In a strategic move to accelerate the development and launch of genetic medicines, BridgeBio Pharma has successfully secured up to $1.25 bn\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BridgeBio Pharma to Propel Genetic Medicine Development | Blog\" \/>\n<meta property=\"og:description\" content=\"In a strategic move to accelerate the development and launch of genetic medicines, BridgeBio Pharma has successfully secured up to $1.25 bn\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-19T13:19:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-19T13:19:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2024\/01\/Roots-Analysis-FeaturedImage-BridgeBio.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"175\" \/>\n\t<meta property=\"og:image:height\" content=\"58\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Pemba Lahmo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pemba Lahmo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/\"},\"author\":{\"name\":\"Pemba Lahmo\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/c2638a51cbfc10884ecca0f902c12b25\"},\"headline\":\"BridgeBio Pharma Secures $1.25 Billion to Propel Genetic Medicine Development\",\"datePublished\":\"2024-01-19T13:19:03+00:00\",\"dateModified\":\"2024-01-19T13:19:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/\"},\"wordCount\":325,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Roots-Analysis-FeaturedImage-BridgeBio.webp\",\"keywords\":[\"BridgeBio\",\"Genetic Medicines\",\"laboratory tests\"],\"articleSection\":[\"Biopharmaceutical\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/\",\"name\":\"BridgeBio Pharma to Propel Genetic Medicine Development | Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Roots-Analysis-FeaturedImage-BridgeBio.webp\",\"datePublished\":\"2024-01-19T13:19:03+00:00\",\"dateModified\":\"2024-01-19T13:19:05+00:00\",\"description\":\"In a strategic move to accelerate the development and launch of genetic medicines, BridgeBio Pharma has successfully secured up to $1.25 bn\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Roots-Analysis-FeaturedImage-BridgeBio.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Roots-Analysis-FeaturedImage-BridgeBio.webp\",\"width\":175,\"height\":58,\"caption\":\"This is a feature image for blog article - Bridgebio at Roots Analysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/bridgebio-pharma-secures-billion-dollar-investment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio Pharma Secures $1.25 Billion to Propel Genetic Medicine Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/c2638a51cbfc10884ecca0f902c12b25\",\"name\":\"Pemba Lahmo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/36c2acf3152647d45468f8cbfe5a9f02af7681f846c70eb2458b18e945dedb1c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/36c2acf3152647d45468f8cbfe5a9f02af7681f846c70eb2458b18e945dedb1c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/36c2acf3152647d45468f8cbfe5a9f02af7681f846c70eb2458b18e945dedb1c?s=96&d=mm&r=g\",\"caption\":\"Pemba Lahmo\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BridgeBio Pharma to Propel Genetic Medicine Development | Blog","description":"In a strategic move to accelerate the development and launch of genetic medicines, BridgeBio Pharma has successfully secured up to $1.25 bn","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/","og_locale":"en_US","og_type":"article","og_title":"BridgeBio Pharma to Propel Genetic Medicine Development | Blog","og_description":"In a strategic move to accelerate the development and launch of genetic medicines, BridgeBio Pharma has successfully secured up to $1.25 bn","og_url":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2024-01-19T13:19:03+00:00","article_modified_time":"2024-01-19T13:19:05+00:00","og_image":[{"width":175,"height":58,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2024\/01\/Roots-Analysis-FeaturedImage-BridgeBio.webp","type":"image\/webp"}],"author":"Pemba Lahmo","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Pemba Lahmo","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/"},"author":{"name":"Pemba Lahmo","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/c2638a51cbfc10884ecca0f902c12b25"},"headline":"BridgeBio Pharma Secures $1.25 Billion to Propel Genetic Medicine Development","datePublished":"2024-01-19T13:19:03+00:00","dateModified":"2024-01-19T13:19:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/"},"wordCount":325,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2024\/01\/Roots-Analysis-FeaturedImage-BridgeBio.webp","keywords":["BridgeBio","Genetic Medicines","laboratory tests"],"articleSection":["Biopharmaceutical"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/","url":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/","name":"BridgeBio Pharma to Propel Genetic Medicine Development | Blog","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2024\/01\/Roots-Analysis-FeaturedImage-BridgeBio.webp","datePublished":"2024-01-19T13:19:03+00:00","dateModified":"2024-01-19T13:19:05+00:00","description":"In a strategic move to accelerate the development and launch of genetic medicines, BridgeBio Pharma has successfully secured up to $1.25 bn","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2024\/01\/Roots-Analysis-FeaturedImage-BridgeBio.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2024\/01\/Roots-Analysis-FeaturedImage-BridgeBio.webp","width":175,"height":58,"caption":"This is a feature image for blog article - Bridgebio at Roots Analysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/bridgebio-pharma-secures-billion-dollar-investment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"BridgeBio Pharma Secures $1.25 Billion to Propel Genetic Medicine Development"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/c2638a51cbfc10884ecca0f902c12b25","name":"Pemba Lahmo","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/36c2acf3152647d45468f8cbfe5a9f02af7681f846c70eb2458b18e945dedb1c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/36c2acf3152647d45468f8cbfe5a9f02af7681f846c70eb2458b18e945dedb1c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/36c2acf3152647d45468f8cbfe5a9f02af7681f846c70eb2458b18e945dedb1c?s=96&d=mm&r=g","caption":"Pemba Lahmo"}}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/20740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/70"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=20740"}],"version-history":[{"count":3,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/20740\/revisions"}],"predecessor-version":[{"id":20746,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/20740\/revisions\/20746"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/20744"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=20740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=20740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=20740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}